Welcome to the Portfolio: C. Light Technologies raises $2.5M seed round to commercialize first ever retinal eye-tracking device for neurodegenerative disease

c light.png

C. Light Technologies, a Berkeley-based neurotech company pioneering the next generation of neurological health assessment tools using the first ever 10-second retinal eye-tracking scan for neurological disease, today announced the closing of their $2.5 million seed round. Their proprietary tracking technology, paired with advanced analytics, is poised to redefine the neurodegenerative space - providing new hope for millions of people worldwide. Read the press release